hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06281145 id: RSV-SK001/UC-SK004/OUSA briefTitle: Stress-Reducing Intervention in Patients With Colorectal and Breast Cancer acronym: SRI-BrCa_CRC overallStatus: RECRUITING date: 2024-03-15 date: 2027-03-15 date: 2029-03-15 date: 2024-02-28 date: 2024-02-28 name: Comenius University class: OTHER briefSummary: The goal of this interventional study is to test the heart-rate variability biofeedback intervention (HRV BI) in 2 cohorts of patients. Cohort A will evaluate the effect of the addition of HRV BI in patients with breast cancer treated in the neoadjuvant setting (vs. standard of care alone, SOC) followed by local therapy (surgery +/-radiotherapy). Cohort B will evaluate the effect of the addition of HRV BI in patients with colon cancer after surgery in the adjuvant setting (vs. standard of care alone, SOC). conditions: Breast Cancer conditions: Colon Cancer studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: The study consists of two cohorts (breasts cancer and colorectal cancer) with two arms SOC + intervention vs SOC alone. primaryPurpose: SUPPORTIVE_CARE masking: NONE count: 100 type: ESTIMATED name: Heart-rate variability biofeedback intervention measure: Primary endpoint - inflammation measure: Primary endpoint - QoL measure: Primary endpoint - executive functions measure: Primary endpoint- salivary cortisol slopes measure: Primary endpoint- sleep quality measure: Primary endpoint - heart rate variability (HRV) measure: Primary endpoint - Working memory measure: Secondary endpoint - Pathologic Complete Response (pCR) and Residual Cancer Burden (RCB) rate in cohort A measure: Secondary endpoint - Relapse-free Survival (RFS) measure: Secondary endpoint - Overall survival (OS) measure: Secondary endpoint - Serious Adverse Events (SAE) sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: St. Elizabeth Cancer Institute status: RECRUITING city: Bratislava zip: 81250 country: Slovakia name: Bela Mrinakova, MD role: CONTACT phone: 00421232249111 email: bela.mrinakova@ousa.sk name: Miriam Hancinova, MD role: CONTACT phone: 00421232249111 email: miriam.hancinova@ousa.sk name: Bela Mrinakova role: PRINCIPAL_INVESTIGATOR name: Miriam Hancinova role: SUB_INVESTIGATOR lat: 48.14816 lon: 17.10674 hasResults: False
nctId: NCT06281132 id: A126_03BE2316 briefTitle: Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy Adults overallStatus: ACTIVE_NOT_RECRUITING date: 2024-03-22 date: 2024-05-07 date: 2024-05-14 date: 2024-02-28 date: 2024-04-02 name: Chong Kun Dang Pharmaceutical class: INDUSTRY briefSummary: The objective was to evaluate and compare the pharmacokinetic profiles and safety after administration of test drug (CKD-341) and reference drugs (D956) in healthy adults. conditions: Hypertension studyType: INTERVENTIONAL phases: PHASE1 allocation: RANDOMIZED interventionModel: CROSSOVER primaryPurpose: TREATMENT masking: NONE count: 48 type: ACTUAL name: CKD-341, D956 measure: area under curve(AUC) of CKD-341, D956 measure: Cmax of CKD-341, D956 sex: ALL minimumAge: 19 Years maximumAge: 55 Years stdAges: ADULT facility: Jeonbuk National University Hospital city: Jeonju country: Korea, Republic of lat: 35.82194 lon: 127.14889 hasResults: False
nctId: NCT06281106 id: IM011-1118 id: KOFAM 2023-01731 type: OTHER domain: CER-VD briefTitle: TYK2 Inhibition in Paradoxical Psoriasis acronym: TYPP overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2025-08 date: 2025-08 date: 2024-02-28 date: 2024-02-28 name: Prof Curdin Conrad class: OTHER name: Centre Hospitalier Universitaire Vaudois briefSummary: Paradoxical psoriasis is a side effect of a biological treatment (anti-tumor necrosis factor agent, short called anti-TNF) that is used to treat diseases of the skin, the intestine or the joints. If paradoxical psoriasis occurs, the anti-TNF-treatment often needs to be stopped and so far, no specific treatment for paradoxical psoriasis exists.
This research project aims to study whether the efficacy of the drug 'Deucravacitinib' 6mg, a tablet taken by mouth once a day is superior compared to taking a placebo in treating paradoxical psoriasis. conditions: Psoriasis studyType: INTERVENTIONAL phases: PHASE2 phases: PHASE3 allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: During 4 weeks the patients of the 2 arms receive either Deucravacitinib 6mg 1x/day or an identically looking placebo.
Patients with underlying disease of psoriasis or psoriatic arthritis will have the possiblity to continue in Part 2, where they all will receive Deucravacitinib 6mg 1x/day, open label for 3 months primaryPurpose: TREATMENT masking: QUADRUPLE maskingDescription: Lab personnel whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 26 type: ESTIMATED name: Deucravacitinib measure: Paradoxical Psoriasis Investigator Global Assessment measure: Paradoxical Psoriasis Body Surface Area measure: Paradoxical Psoriasis palmoplantar Psoriasis Area and Severity Index measure: Paradoxical Psoriasis Scalp Investigator General Assessment measure: Psoriasis Area and Severity Index (PASI) measure: American College of Rheumatology (ACR) Score measure: Nanostring sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Centre hospitalier universitaire vaudois (CHUV) city: Lausanne state: VD zip: 1011 country: Switzerland name: Franziska Stuber, RN role: CONTACT phone: +41 21 3143427 email: franziska.stuber@chuv.ch name: Curdin Conrad, Professor role: PRINCIPAL_INVESTIGATOR lat: 46.516 lon: 6.63282 hasResults: False
nctId: NCT06281093 id: PI2022_843_0089 briefTitle: Radiofrequency Fields in Neonatology: Exposure and Impact on the Nervous System acronym: CHARLINE overallStatus: RECRUITING date: 2024-02-20 date: 2026-09 date: 2026-10 date: 2024-02-28 date: 2024-03-13 name: Centre Hospitalier Universitaire, Amiens class: OTHER name: University Hospital, Brest name: CHU LYON name: University Hospital, Strasbourg, France name: University Hospital, Toulouse briefSummary: Previously, the investigators showed that preterm newborns are exposed chronically to very low radiofrequency levels in average while hospitalized in NICUs. Most of the infants were nevertheless frequently exposed to transient values above 1 V/m. The investigators also showed that an increase in RF exposure is likely to alter the activity of some neurophysiological functions and their regulatory systems in preterm newborns. The investigators hypothesize that above results are extremely specific to the location of the previous study and may be different in other NICU environments.
This study will aim at quantifying RF levels to which preterm newborns are exposed during their stay in several NICUs spread across the French territory, and assessing its impact on the central and peripheral nervous systems. The first step of this study will be to quantify the precise, continuous and individual levels of daily RF exposure to which each recruited neonate is subjected during his stay in the different NICUs from birth to 1 week postnatal life. Infants' clinical data (medical history, nutrition, morphology...) will also be continually monitored. At 1 week postnatal life, the investigators will investigate cerebral activity (EEG) and autonomic nervous system activity (ECG, heart rate variability). The impact of RF will be evaluated by analyses of the relationship between exposure levels and the various parameters extracted from the neurophysiological investigation phase. conditions: Preterm Newborn studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: BASIC_SCIENCE masking: NONE count: 200 type: ESTIMATED name: questionary name: Daily continuous recording of radiofrequency exposure levels name: Follow-up of daily infants clinical parameters name: recording of cerebral (EEG) name: autonomic nervous (ECG) activity measure: Variation of the spectral power in the α band (8-12 Hz) of the EEG measure: variation of the spectral power in the delta (δ, 0.5-4 Hz) of the EEG sex: ALL minimumAge: 1 Day maximumAge: 1 Month stdAges: CHILD facility: Amiens University Hospital status: RECRUITING city: Amiens state: Picardie zip: 80054 country: France name: Pierre Tourneux, MD role: CONTACT phone: +33 3 22 66 82 86 email: tourneux.pierre@chu-amiens.fr name: Erwan STÉPHAN-BLANCHARD, Dr role: PRINCIPAL_INVESTIGATOR name: Stéphane DELANAUD, PhD role: SUB_INVESTIGATOR name: Frédéric TELLIEZ, Pr role: SUB_INVESTIGATOR name: Karen CHARDON, Pr role: SUB_INVESTIGATOR name: Brahim SELMAOUI, Dr role: SUB_INVESTIGATOR name: Débora TUKA role: SUB_INVESTIGATOR name: Jean-Michel ROUÉ, Pr role: PRINCIPAL_INVESTIGATOR name: Marine BUTIN, Pr role: PRINCIPAL_INVESTIGATOR name: Pierre KUHN, Pr role: PRINCIPAL_INVESTIGATOR name: Géraldine GASCOIN, Pr role: PRINCIPAL_INVESTIGATOR lat: 49.9 lon: 2.3 hasResults: False
nctId: NCT06281080 id: CRE2023.589-T briefTitle: First-in-Human Trial of a Novel Endoluminal Robotic System for En-Bloc Resection of Bladder Tumours overallStatus: NOT_YET_RECRUITING date: 2024-07-01 date: 2025-06-30 date: 2025-09-30 date: 2024-02-28 date: 2024-02-28 name: Chinese University of Hong Kong class: OTHER name: Agilis Robotics Limited briefSummary: This is a prospective, single-arm study to evaluate the feasibility and safety of performing transurethral en-bloc resection of bladder tumours using the Zenith robotic system. conditions: Bladder Cancer studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 10 type: ESTIMATED name: En-Bloc Resection of Bladder Tumours measure: Successful en-bloc tumour resection by the robotic system measure: Dissection time and speed measure: Total procedure time measure: Surgeon Console time measure: Presence of detrusor muscle in specimen measure: Resection Margin measure: Intra-operative bladder perforation event measure: Post-operative complications measure: Need of bladder irrigation measure: Residual tumour or upstaging of tumour after second look TURBT sex: ALL minimumAge: 18 Years maximumAge: 75 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06281067 id: 271.673 briefTitle: Reassessment of myocardIAL Bridge TOwards PeRsOnalized Medicine acronym: RIALTO PRO overallStatus: RECRUITING date: 2023-12-15 date: 2026-01-01 date: 2026-01-01 date: 2024-02-28 date: 2024-02-28 name: Azienda Ospedaliero Universitaria Maggiore della Carita class: OTHER name: Università degli Studi del Piemonte Orientale "Amedeo Avogadro" briefSummary: The "RIALTO-PRO" study aims to optimize the diagnostic and therapeutic algorithm for myocardial bridge (MB) patients, testing the diagnostic value of a full invasive diagnostic procedure, and, consequently, the prognostic value of a tailored approach. the study objective is to determine the diagnostic and prognostic value of a full-physiology approach strategy versus a standard approach strategy in patients with a MB.
nctId: NCT06281054 id: SMC2023-12-027 briefTitle: Acute Myocardial Infarction in Cancer Patients overallStatus: ACTIVE_NOT_RECRUITING date: 2002-01-01 date: 2021-12-31 date: 2024-12-31 date: 2024-02-28 date: 2024-02-28 name: Samsung Medical Center class: OTHER name: Chonnam National University briefSummary: Using national health insurance service database, current study aim to evaluate the risk and prognosis of acute myocardial infarction in cancer patients and to find the optimal treatment strategy for acute myocardial infarction that can improve long-term prognosis. conditions: Acute Myocardial Infarction conditions: Cancer studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 4500000 type: ESTIMATED name: Revascularization measure: All-cause death measure: Myocardial infarction measure: Revascularization measure: Hospitalization for heart failure measure: Stroke measure: Clinically relevant bleeding sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Chonnam National University Hospital, Chonnam National University Medical School city: Gwangju country: Korea, Republic of lat: 35.15472 lon: 126.91556 hasResults: False
nctId: NCT06281041 id: NHIS20240220 briefTitle: Nationwide Cohort Study of Antiplatelet Agents as Primary Prevention acronym: NHIS overallStatus: ACTIVE_NOT_RECRUITING date: 2013-01-01 date: 2020-12-31 date: 2024-12-31 date: 2024-02-28 date: 2024-02-28 name: Samsung Medical Center class: OTHER name: Chonnam National University briefSummary: There is no specific recommendation regarding pharmacologic treatment as primary prevention for patients with intermediate coronary artery stenosis whose revascularization was deferred based on negative fractional flow reserve (FFR).
Current nationwide cohort study conducted using Korean National Health Insurance Service database evaluated the safety and efficacy of antiplatelet therapy in patients with intermediate coronary artery stenosis with deferred revascularization based on negative FFR (FFR\>0.80). conditions: Coronary Artery Disease conditions: Coronary Artery Stenosis studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 4657 type: ACTUAL name: Antiplatelet Agents measure: Major adverse cardiac and cerebrovascular events measure: Gastrointestinal bleeding measure: All-cause death measure: Myocardial infarction measure: Unplanned revascularization measure: Stroke measure: Major bleeding measure: Gastrointestinal bleeding necessitated hospitalization without documented transfusion measure: Intracranial hemorrhage sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Chonnam National University Medical School city: Gwangju country: Korea, Republic of lat: 35.15472 lon: 126.91556 hasResults: False
nctId: NCT06281028 id: 2023-A02280-45 briefTitle: SOLACEA-H in Heparin-sparing Haemodialysis acronym: SOLHEPA overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2025-09 date: 2025-09 date: 2024-02-28 date: 2024-02-28 name: GCS Ramsay Santé pour l'Enseignement et la Recherche class: OTHER briefSummary: The aim of the study is to evaluate the efficacy of the SOLACEA-H dialyser, particularly in patients at high risk of haemorrhage, during post-dilution haemodiafiltration sessions with complete or partial heparin sparing. It will be compared with another dialyser (HYDROLINK-NVU) conditions: Dialysis Membrane Reaction studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: CROSSOVER interventionModelDescription: Prospective, multicenter, randomized primaryPurpose: TREATMENT masking: NONE count: 19 type: ESTIMATED name: SOLACEA-H/HYDROLINK-NVU name: HYDROLINK-NVU/SOLACEA-H measure: SOLACEA-H vs HYDROLINK-NVU efficacy sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Hôpital Privé La Louvière city: Lille zip: 59800 country: France name: Maxime HOFFMANN, MD role: CONTACT phone: 6 86 70 91 23 phoneExt: +33 email: maxime.hoffmann@gmail.com lat: 50.63297 lon: 3.05858 hasResults: False
nctId: NCT06281015 id: 2023PI095-407 briefTitle: Artificial Intelligence and Bone Tomoscintigraphies Achieved With CZT Camera acronym: IATOS overallStatus: COMPLETED date: 2023-08-30 date: 2023-09-10 date: 2023-10-30 date: 2024-02-28 date: 2024-02-28 name: Central Hospital, Nancy, France class: OTHER briefSummary: This study aimed to determine whether the whole-body bone Single Photon Emission Computed Tomography (SPECT) recording times of around 10 minutes, routinely provided by a high-sensitivity 360 degrees cadmium and zinc telluride (CZT) camera, can be further reduced by a deep learning noise reduction (DLNR) algorithm. conditions: Bone Lesion studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: RETROSPECTIVE count: 19 type: ACTUAL name: Whole-body bone single photon emission tomography (SPECT) for detection or follow-up of bone metastasis measure: Assess a dedicated deep learning noise reduction algorithm sex: ALL minimumAge: 18 Years maximumAge: 95 Years stdAges: ADULT stdAges: OLDER_ADULT facility: CHRU Nancy city: Vandoeuvre les Nancy cedex zip: 54511 country: France lat: 48.65 lon: 6.18333 hasResults: False
nctId: NCT06281002 id: FDASU-RecIM112323 briefTitle: Trueness of Full Arch Scans and Generated Digital Implant Models overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2024-10 date: 2024-12 date: 2024-02-28 date: 2024-03-06 name: Ain Shams University class: OTHER briefSummary: The goal of this clinical trial study is to evaluate the accuracy of the full digital workflow for four-implant, screw-retained mandibular hybrid prostheses in patients with completely edentulous mandible. conditions: Denture conditions: Complete Edentulism studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: CROSSOVER primaryPurpose: TREATMENT masking: SINGLE whoMasked: PARTICIPANT count: 9 type: ESTIMATED name: conventional impression stone casts digitization name: digital scanning with coupled scanning aiding device name: Digital Implant Model assessment of accuracy measure: Trueness of full arch digital scans when additional geometric scanning aids are coupled with the scan bodies. measure: Trueness of the generated 3D-printed digital implant models. sex: ALL minimumAge: 45 Years maximumAge: 60 Years stdAges: ADULT hasResults: False
nctId: NCT06280989 id: P.T.REC/012/004768 briefTitle: Effect of Kinesio Taping Versus Myofascial Release on Menstrual Low Back Pain overallStatus: NOT_YET_RECRUITING date: 2024-03-15 date: 2024-07 date: 2024-08 date: 2024-02-28 date: 2024-02-29 name: Cairo University class: OTHER briefSummary: the aim of this study is to investigate the efficacy of kinesio taping versus myofascial release technique on menstrual low back pain in young females conditions: Low Back Pain studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: kinesio taping and myofascial release technique primaryPurpose: TREATMENT masking: DOUBLE whoMasked: PARTICIPANT whoMasked: OUTCOMES_ASSESSOR count: 44 type: ESTIMATED name: kinesio taping name: myofascial release technique measure: pain intensity measure: pain pressure threshold measure: severity of dysmenorrhea measure: Assess the function disability level sex: FEMALE minimumAge: 18 Years maximumAge: 25 Years stdAges: ADULT facility: Hala mohamed ahmed morsy city: Giza zip: 12511 country: Egypt name: hala ma morsy, Bachelor role: CONTACT phone: 00201028616865 email: halamohamed8.11.2018@gmail.com lat: 30.00808 lon: 31.21093 hasResults: False
nctId: NCT06280963 id: 012/005532 briefTitle: Posterior Innominate Mobilization Versus Muscle Energy Technique on Lumbopelvic Angles in Sacroiliac Joint Dysfunction acronym: MET overallStatus: RECRUITING date: 2024-02-01 date: 2024-06-01 date: 2024-08-03 date: 2024-02-28 date: 2024-02-28 name: Mahmoud Yousry Rashwan Hefny class: OTHER briefSummary: the goal of this clinical trial study is to compare between posterior innominate mobilization and muscle energy techniqueon lumbopelvic angles in sacroiliac joint dysfunction patients.
* purpose of the study is to measure the effect of muscle energy technique versus posterior innominate mobilization on lumbopelvic angles in sacroiliac joint dysfunction conditions: Sacroiliac Joint Dysfunction studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: FACTORIAL interventionModelDescription: group one will receive muscle energy technique group two will receive posterior innominate mobilization group three will receive conventional treatment ( TENS , US , stertching exercises and strenghening exercises ) primaryPurpose: TREATMENT masking: SINGLE whoMasked: PARTICIPANT count: 60 type: ESTIMATED name: muscle energy technique name: posterior innominate mobilization name: conventional treatment measure: lumbopelvic angles measure: pain intensity sex: ALL minimumAge: 25 Years maximumAge: 45 Years stdAges: ADULT facility: Faculty of Physical Therapy status: RECRUITING city: Dokki state: Giza zip: 12612 country: Egypt name: Haytham M Elhafez, PhD role: CONTACT phone: +201001909630 email: elhafez@yahoo.com lat: 30.03823 lon: 31.2113 hasResults: False
nctId: NCT06280937 id: BEUFTR-2 briefTitle: Short Term Effect of Wearing a Tie overallStatus: NOT_YET_RECRUITING date: 2024-03-01 date: 2024-08-01 date: 2024-10-01 date: 2024-02-28 date: 2024-02-28 name: Bitlis Eren University class: OTHER briefSummary: The goal of this randomized controlled study is to assess the short term effect of wearing a ties on musculoskeletal system. In this scope viscoelastic properties and the mechanosensitivity of the muscles, and cervical range of motion will be measured. In addition to these measurements activity limitation due to wearing a tie and trunk mobility will be assessed. conditions: Musculoskeletal Disorder studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Control group will go on their routine daily activities. Study group will wear a tie during one office working day. primaryPurpose: PREVENTION masking: SINGLE maskingDescription: Interventions and assessment will be performed by separate researchers. whoMasked: OUTCOMES_ASSESSOR count: 54 type: ESTIMATED name: Wearing a tie measure: The Change in the Viscoelastic Properties of the Muscles measure: The Change in the Pressure Pain Threshold of the Spine and Upper Trapezius measure: Cervical Range of Motion measure: Activity Limitation measure: Global Rating of Change measure: Trunk Forward Bending Mobility measure: Trunk Lateral Bending Mobility measure: Neck Circumference sex: MALE minimumAge: 18 Years maximumAge: 25 Years stdAges: ADULT facility: Bitlis Eren University city: Bitlis state: Merkez zip: 13000 country: Turkey lat: 38.40115 lon: 42.10784 hasResults: False
nctId: NCT06280924 id: HREBA.CC-23-0220 briefTitle: Prehab Prior to Stem Cell Transplantation in Multiple Myeloma acronym: MOTIVATE overallStatus: NOT_YET_RECRUITING date: 2024-04-15 date: 2025-12-31 date: 2026-06-30 date: 2024-02-28 date: 2024-02-28 name: University of Alberta class: OTHER briefSummary: The primary purpose of this study is to see if individuals with Multiple Myeloma are able and interested in taking part in a tailored exercise program while undergoing their chemotherapy prior to a stem cell transplant. We also hope to learn if this type of program, along with a flexible delivery format (in-person and virtual), helps in maintaining or improving physical fitness, muscle mass and strength, and quality of life during chemotherapy. conditions: Multiple Myeloma conditions: Exercise conditions: Prehabilitation studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Randomized controlled trial primaryPurpose: SUPPORTIVE_CARE masking: SINGLE maskingDescription: An independent assessor will conduct the post-intervention assessment. The independent assessor will be blinded to group assignment. whoMasked: OUTCOMES_ASSESSOR count: 30 type: ESTIMATED name: Supported Exercise name: Standard Care measure: Study completion rate measure: Recruitment rate measure: Attendance rate measure: Edmonton Symptom Assessment System measure: Functional Assessment of Cancer Therapy Multiple Myeloma measure: Functional Assessment of Cancer Therapy: Fatigue Subscale (13-item) measure: Body weight measure: Body height measure: Grip Strength measure: Calf muscle size measure: Thigh muscle thickness measure: Short Physical Performance Battery measure: Six-minute walk test measure: One leg stance balance measure: Shoulder flexion range of motion measure: Sit and reach test sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University of Alberta/ Cross Cancer Institute city: Edmonton state: Alberta zip: T6G 2G4 country: Canada lat: 53.55014 lon: -113.46871 hasResults: False